Genital tract chlamydia infection

Nwokolo NC, Dragovic B, Patel S, et al. 2015 UK national guideline for the management of infection with Chlamydia trachomatis. Int J STD AIDS. 2016 Mar;27(4):251-67.Full text  Abstract

Rowley J, Vander Hoorn S, Korenromp E, et al. Chlamydia, gonorrhoea, trichomoniasis and syphilis: global prevalence and incidence estimates, 2016. Bull World Health Organ. 2019 Aug 1;97(8):548-562P.Full text  Abstract

Centers for Disease Control and Prevention. Sexually transmitted infections surveillance: national overview of STIs, 2022. Jan 2024 [internet publication].Full text

Workowski KA, Bachmann LH, Chan PA, et al. Sexually transmitted infections treatment guidelines, 2021. MMWR Recomm Rep. 2021 Jul 23;70(4):1-187.Full text  Abstract

US Preventive Services Task Force. Final recommendation statement. Chlamydia and gonorrhea: screening. Sept. 2021 [internet publication].Full text

Geisler WM, Uniyal A, Lee JY, et al. Azithromycin versus doxycycline for urogenital chlamydia trachomatis Infection. N Engl J Med. 2015 Dec 24;373(26):2512-21.Full text  Abstract

American College of Obstetricians and Gynecologists. Committee opinion no. 737: expedited partner therapy. Jun 2018 [internet publication].Full text

1. Torrone E, Papp J, Weinstock H. Prevalence of Chlamydia trachomatis genital infection among persons aged 14-39 years--United States, 2007-2012. MMWR Morb Mortal Wkly Rep. 2014 Sep 26;63(38):834-8.Full text  Abstract

2. Nwokolo NC, Dragovic B, Patel S, et al. 2015 UK national guideline for the management of infection with Chlamydia trachomatis. Int J STD AIDS. 2016 Mar;27(4):251-67.Full text  Abstract

3. Rowley J, Vander Hoorn S, Korenromp E, et al. Chlamydia, gonorrhoea, trichomoniasis and syphilis: global prevalence and incidence estimates, 2016. Bull World Health Organ. 2019 Aug 1;97(8):548-562P.Full text  Abstract

4. Centers for Disease Control and Prevention. Sexually transmitted infections surveillance: national overview of STIs, 2022. Jan 2024 [internet publication].Full text

5. Workowski KA, Bachmann LH, Chan PA, et al. Sexually transmitted infections treatment guidelines, 2021. MMWR Recomm Rep. 2021 Jul 23;70(4):1-187.Full text  Abstract

6. Public Health England. Sexually transmitted infections and screening for chlamydia in England, 2019. Dec 2019 [internet publication].Full text

7. Bachmann NL, Polkinghorne A, Timms P. Chlamydia genomics: providing novel insights into chlamydial biology. Trends Microbiol. 2014 Aug;22(8):464-72. Abstract

8. Elwell C, Mirrashidi K, Engel J. Chlamydia cell biology and pathogenesis. Nat Rev Microbiol. 2016 Jun;14(6):385-400.Full text  Abstract

9. Scidmore MA. Cultivation and laboratory maintenance of Chlamydia trachomatis. Curr Protoc Microbiol. 2005 Jul;Chapter 11:Unit 11A.1. Abstract

10. Mertz KJ, McQuillan GM, Levine WC, et al. A pilot study of the prevalence of chlamydia infection in a national household survey. Sex Transm Dis. 1998 May;25(5):225-8. Abstract

11. U.S. Preventive Services Task Force. Sexually transmitted infections: Behavioral counseling. Aug 2020 [internet publication].Full text

12. Public Health England. NCSP: programme overview. Jun 2021 [internet publication].Full text

13. National Institute for Health and Care Excellence. Reducing sexually transmitted infections. June 2022 [internet publication].Full text

14. McClean H, Radcliffe K, Sullivan A, et al. 2012 BASHH statement on partner notification for sexually transmissible infections. Int J STD AIDS. 2013 Apr;24(4):253-61. Abstract

15. Stamm WE. Chlamydia trachomatis infections: progress and problems. J Infect Dis. 1999 Mar;179(suppl 2):S380-3.Full text  Abstract

16. Cecil JA, Howell MR, Tawes JJ, et al. Features of Chlamydia trachomatis and Neisseria gonorrhoeae infection in male Army recruits. J Infect Dis. 2001 Nov 1;184(9):1216-9. Abstract

17. Centers for Disease Control and Prevention. Recommendations for the laboratory-based detection of Chlamydia trachomatis and Neisseria gonorrhoeae - 2014. MMWR Recomm Rep. 2014 Mar 14;63(RR-02):1-19.Full text  Abstract

18. Moncada J, Schachter J, Liska S, et al. Evaluation of self-collected glans and rectal swabs from men who have sex with men for detection of Chlamydia trachomatis and Neisseria gonorrhoeae by use of nucleic acid amplification tests. J Clin Microbiol. 2009 Jun;47(6):1657-62.Full text  Abstract

19. Cosentino LA, Campbell T, Jett A, et al. Use of nucleic acid amplification testing for diagnosis of anorectal sexually transmitted infections. J Clin Microbiol. 2012 Jun;50(6):2005-8.Full text  Abstract

20. Kelly H, Coltart CEM, Pant Pai N, et al. Systematic reviews of point-of-care tests for the diagnosis of urogenital Chlamydia trachomatis infections. Sex Transm Infect. 2017 Dec;93(S4):S22-S30.Full text  Abstract

21. May L, Ware CE, Jordan JA, et al. A randomized controlled trial comparing the treatment of patients tested for chlamydia and gonorrhea after a rapid polymerase chain reaction test versus standard of care testing. Sex Transm Dis. 2016 May;43(5):290-5. Abstract

22. Unemo M, Bradshaw CS, Hocking JS, et al. Sexually transmitted infections: challenges ahead. Lancet Infect Dis. 2017 Aug;17(8):e235-79. Abstract

23. Van Der Pol B, Taylor SN, Mena L, et al. Evaluation of the performance of a point-of-care test for Chlamydia and Gonorrhea. JAMA Netw Open. 2020 May 1;3(5):e204819.Full text  Abstract

24. Hoebe CJ, Rademaker CW, Brouwers EE, et al. Acceptability of self-taken vaginal swabs and first-catch urine samples for the diagnosis of urogenital Chlamydia trachomatis and Neisseria gonorrhoeae with an amplified DNA assay in young women who attend a public health sexually transmitted disease clinic. Sex Transm Dis. 2006 Aug;33(8):491-5. Abstract

25. Whitlock GG, Gibbons DC, Longford N, et al. Rapid testing and treatment for sexually transmitted infections improve patient care and yield public health benefits. Int J STD AIDS. 2018 Apr;29(5):474-82.Full text  Abstract

26. Gaydos CA, Ferrero DV, Papp J. Laboratory aspects of screening men for Chlamydia trachomatis in the new millennium. Sex Transm Dis. 2008 Nov;35(11 suppl):S45-50. Abstract

27. US Preventive Services Task Force. Final recommendation statement. Chlamydia and gonorrhea: screening. Sept. 2021 [internet publication].Full text

28. US Public Health Service. Preexposure prophylaxis for the prevention of HIV infection in the United States - 2017 update. Mar 2018 [internet publication].Full text

29. American Academy of Family Physicians. Summary of recommendations for clinical preventive services. July 2017 [internet publication].Full text

30. World Health Organization. WHO guideline on self-care interventions for health and well-being, 2022 revision. 2022 [internet publication].Full text

31. National Institute for Health and Care Excellence. Antenatal care for uncomplicated pregnancies. Feb 2019 [internet publication].Full text

32. Geisler WM, Uniyal A, Lee JY, et al. Azithromycin versus doxycycline for urogenital chlamydia trachomatis Infection. N Engl J Med. 2015 Dec 24;373(26):2512-21.Full text  Abstract

33. Rusu A, Munteanu AC, Arbănași EM, et al. Overview of side-effects of antibacterial fluoroquinolones: new drugs versus old drugs, a step forward in the safety profile? Pharmaceutics. 2023 Mar 1;15(3):804.Full text  Abstract

34. Cluver C, Novikova N, Eriksson DO, et al. Interventions for treating genital Chlamydia trachomatis infection in pregnancy. Cochrane Database Syst Rev. 2017;(9):CD010485.Full text  Abstract

35. Centers for Disease Control and Prevention. Expedited partner therapy in the management of sexually transmitted diseases. 2006 [internet publication].Full text

36. American College of Obstetricians and Gynecologists. Committee opinion no. 737: expedited partner therapy. Jun 2018 [internet publication].Full text

37. Lau CY, Qureshi AK. Azithromycin versus doxycycline for genital chlamydial infections: a meta-analysis of randomized clinical trials. Sex Transm Dis. 2002 Sep;29(9):497-502. Abstract

38. Páez-Canro C, Alzate JP, González LM, et al. Antibiotics for treating urogenital Chlamydia trachomatis infection in men and non-pregnant women. Cochrane Database Syst Rev. 2019 Jan 25;1:CD010871.Full text  Abstract

39. Xia Q, Wang T, Xian J, et al. Relation of chlamydia trachomatis infections to ectopic pregnancy: a meta-analysis and systematic review. Medicine (Baltimore). 2020 Jan;99(1):e18489.Full text  Abstract

40. Ahmadi MH, Mirsalehian A, Bahador A. Prevalence of genital Chlamydia trachomatis in Iran: a systematic review and meta-analysis. Pathog Glob Health. 2015 Sep;109(6):290-9.Full text  Abstract

41. Chen JZ, Gratrix J, Brandley J, et al. Retrospective review of gonococcal and chlamydial cases of epididymitis at 2 Canadian sexually transmitted infection clinics, 2004-2014. Sex Transm Dis. 2017 Jun;44(6):359-61.Full text  Abstract

42. Denison HJ, Curtis EM, Clynes MA, et al. The incidence of sexually acquired reactive arthritis: a systematic literature review. Clin Rheumatol. 2016 Nov;35(11):2639-48.Full text  Abstract

43. Carter JD, Inman RD. Chlamydia-induced reactive arthritis: hidden in plain sight? Best Pract Res Clin Rheumatol. 2011 Jun;25(3):359-74. Abstract

44. Rich E, Hook EW 3rd, Alarcón GS, et al. Reactive arthritis in patients attending an urban sexually transmitted diseases clinic. Arthritis Rheum. 1996 Jul;39(7):1172-7. Abstract

45. Darling EK, McDonald H. A meta-analysis of the efficacy of ocular prophylactic agents used for the prevention of gonococcal and chlamydial ophthalmia neonatorum. J Midwifery Womens Health. 2010 Jul-Aug;55(4):319-27. Abstract

46. Zhu H, Shen Z, Luo H, et al. Chlamydia trachomatis infection-associated risk of cervical cancer: a meta-analysis. Medicine (Baltimore). 2016 Mar;95(13):e3077.Full text  Abstract